18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)-computed tomography imaging assesses the distribution and treatment response of metabolically active disease lesions. PET imaging using several non-FDG radiotracers has been performed in multiple myeloma (MM). This chapter will answer common questions about PET tracers used in MM, their clinical applications, advantages, and limitations.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Multiple Myeloma

  • Senthil Raja,
  • Hian Liang Huang,
  • Cindy Leung,
  • Gopinath Gnanasegaran

摘要

18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)-computed tomography imaging assesses the distribution and treatment response of metabolically active disease lesions. PET imaging using several non-FDG radiotracers has been performed in multiple myeloma (MM). This chapter will answer common questions about PET tracers used in MM, their clinical applications, advantages, and limitations.